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I. INTRODUCTION
In May 2019, the world governing authority for track and field, the
World Athletics (formerly known as International Association of
Athletics Federations or IAAF)1, instituted new eligibility regulations
1. As this issue went to print, the International Association of Athletics
Federations changed its name to World Athletics; however, some sources in this
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for the female classification (DSD Regulations) that required certain
females, who naturally produce a higher level of testosterone and
compete in the restricted events, to take oral contraceptives.2 The
affected female athletes are now required to reduce their natural level
of testosterone in the name of “fair competition” to participate in the
female category of certain events.3 Along with Athletics South Africa
(ASA), South African middle-distance runner and Olympic gold
medalist, Caster Semenya4, challenged World Athletics’ new
regulations in the Court of Arbitration for Sport (CAS).5 In its
landmark decision, CAS upheld the new regulations as “necessary”
and stated that the regulations made use of “reasonable and
proportional” means to maintain fair competition, even though they
were “prima facie discriminatory.”6
As a member to the Olympic Movement, World Athletics is
required to abide by the World Anti-Doping Code (Code).7 The World
article will still reference its former name. See About World Athletics, WORLD
ATHLETICS, https://www.worldathletics.org/about-iaaf (last visited Dec. 14, 2019)
(explaining that the IAAF is the international governing body for track and field).
2. See IAAF Athletics, Eligibility Regulations for the Female Classification
(Athletes with Differences of Sex Development), 1–4 (May 1, 2019) [hereinafter
Eligibility Regulations for the Female Classification] (establishing new regulations
that impact the eligibility status of intersex athletes).
3. See id. at 1–2 (stating that the purpose of the regulations are to “ensure fair
and meaningful competition”).
4. See generally Athlete Profile: Caster Semenya, WORLD ATHLETICS,
https://www.worldathletics.org/athletes/south-africa/caster-semenya-242560 (last
visited Dec. 14, 2019) (listing Caster Semenya’s events, rankings, personal bests,
and other statistics).
5. See Court of Arbitration for Sport, Executive Summary, 1, 3–5 (Apr. 30,
2019)
[hereinafter
CAS
Executive
Summary],
https://www.tascas.org/fileadmin/user_upload/CAS_Executive_Summary__5794_.pdf
(announcing CAS’s decision to uphold the DSD Regulations); see also Mokgadi
Caster Semenya v. International Association of Athletics Federations [IAAF], CAS
2018/0/5794 & Athletics South Africa v. International Association of Athletics
Federations [IAAF], CAS 2018/0/5798 (Court of Arbitration for Sport, Apr. 30,
2019), https://www.tas-cas.org/fileadmin/user_upload/CAS_Award_-_redacted__Semenya_ASA_IAAF.pdf (hearing both cases together and deciding a joint
award).
6. CAS Executive Summary, supra note 5, at 2–5 (summarizing the arguments
presented by each party and the Court of Arbitration of Sport’s ruling).
7. See Code Signatories, WORLD ANTI-DOPING AGENCY, https://www.wadaama.org/en/what-we-do/the-code/code-signatories (last visited Dec. 14, 2019)
(providing a full list of signatories to the Code).
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Anti-Doping Agency (WADA)8 created the Code to ensure fair
competition by preventing athletes from taking performance
enhancing drugs to gain an unfair advantage over competitors.9 The
Code includes a non-exclusive prohibited list of substances and
methods that athletes (and their respective signatory) are required to
follow.10 The Code prohibits a substance when it (1) has the potential
to harm an athlete’s health and (2) violates the spirit of sport.11
Therefore, as a signatory to the Code, World Athletics is obligated to
comply with the Code by enacting regulations that align with the
overall purpose of fair competition.12
This Comment argues that World Athletics’ new regulations violate
the Code by requiring certain female athletes to undergo testosteronesuppressing treatment that jeopardizes their health and undermines the
spirit of sport. Part II of this Comment begins with an overview of the
roles of relevant international players followed by the path that led to
the enactment of World Athletics regulations.13 Part III first
demonstrates how the regulations inflict unnecessary and
disproportionate health risks on the athletes.14 Part III closes by
arguing that the regulations violate the spirit of sport by unfairly
discriminating against a select group of athletes and violating their

8. See Who We Are, WORLD ANTI-DOPING AGENCY [hereinafter Who We Are,
WORLD ANTI-DOPING AGENCY], https://www.wada-ama.org/en/who-we-are (last
visited Dec. 14, 2019) (explaining WADA’s authority to amend and enforce the
Code).
9. See World Anti-Doping Code (2015 with 2019 amendments), WORLD ANTIDOPING AGENCY [hereinafter World Anti-Doping Code], https://www.wadaama.org/sites/default/files/resources/files/wada_antidoping_code_2019_english_final_revised_v1_linked.pdf.
10. See World Anti-Doping Code, supra note 9, at 28 (“The Prohibited List shall
identify those Prohibited Substances and Prohibited Methods which are prohibited
as doping at all times.”); Prohibited List, WORLD ANTI-DOPING AGENCY (January
2019),
https://www.wadaama.org/sites/default/files/wada_2019_english_prohibited_list.pdf (featuring a list
of prohibited substances).
11. See generally World Anti-Doping Code, supra note 9, at 30 (outlining the
criteria for adding a substance to the prohibited list).
12. Code Signatories, supra note 7 (featuring a list of all the organizations that
comprise the “Olympic Movement”).
13. See infra Part II.
14. See infra Part III(A).
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fundamental rights.15
Lastly, Part IV recommends three reforms.16 First, under the
assumption that testosterone is the determinative factor in athletic
performance, World Athletics should eliminate the binary
classification of male and female and instead implement
classifications based on testosterone levels.17 However, if World
Athletics recognizes that testosterone is not the determinative factor in
athletic performance, or if World Athletics is not ready to remove the
binary divide, then World Athletics should create subclassifications
under both the female and male classifications based on testosterone
levels.18 Finally, WADA should also amend the Code to implement
stronger safeguards for the protection of the athletes and the
foundation of sports.19 These recommendations are designed to
eliminate the restrictions on the natural abilities of intersex athletes
and provide more viable solutions to the issues arising under the newly
recognized spectrum of sex.20

II. BACKGROUND
A. THE INTERNATIONAL PLAYERS
International sport competitions are a long standing tradition with
the first Olympic games dating back to 1896 in Athens, Greece.21 As
time has passed, various committees, federations, agencies, and
organizations with different focuses and specialties have formed to
further the spirit of competition between athletes across the world.22
The three major players in track and field include WADA and the
15. See infra Part III(B).
16. See infra Part IV.
17. See infra Part IV(B)(i).
18. See infra Part IV(B)(ii).
19. See infra Part IV(B)(iii).
20. See infra Part IV.
21. See
generally
Athens
1896,
INT’L OLYMPIC COMMITTEE,
https://www.olympic.org/athens-1896 (last visited Dec. 14, 2019) (describing the
first Olympic Games held in 1896 with athletes from only fourteen nations).
22. See Who We Are, INT’L OLYMPIC COMMITTEE [hereinafter Who We Are,
INT’L OLYMPIC COMMITTEE], https://www.olympic.org/about-ioc-olympicmovement (last visited Dec. 14, 2019) (explaining that the Olympic Movement is a
broad group featuring “national associations, clubs and persons”).
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Code, World Athletics, and CAS.23
i. World Anti-Doping Agency
In response to the doping events of the 1998 Tour de France that
“shook the world of cycling,” the International Olympic Committee
(IOC) established a World Conference on Doping in Sport, which
created an independent anti-doping agency later to be named the
World Anti-Doping Agency.24 WADA became responsible for
creating the core document that harmonizes anti-doping policies,
rules, and regulations within sports organizations around the world.25
Essentially, the Code ensures that international competitions consist
only of athletes performing within their natural abilities.26 The Code
has two main purposes:
[1] To protect the [a]thlete[‘s] fundamental right to participate in dopingfree sport and thus promote health, fairness and equality for Athletes
worldwide, and [2] to ensure harmonized, coordinated and effective antidoping programs at the international and national level with regard to
detection, deterrence and prevention of doping.27

23. Compare Who We Are, WORLD ANTI-DOPING AGENCY, supra note 8
(explaining that WADA plays a role in regulating “all sports,” including those
outside of track and field), and History of the CAS, COURT OF ARBITRATION FOR
SPORT,
https://www.tas-cas.org/en/general-information/history-of-the-cas.html
(last visited Dec. 14, 2019) (explaining that the Court of Arbitration for Sport holds
the authority to hear disputes within all international sports organizations), with
About World Athletics, supra note 1 (noting that IAAF’s authority is limited to
disputes within the sport of track and field).
24. See Probe Reveals Doping by Pantani, Ullrich in 1998, USA TODAY (July
24, 2013), https://www.usatoday.com/story/sports/cycling/2013/07/24/cyclingprobe-doping-by-pantani-ullrich-in-1998/2582769/ 7/24/cycling-probe-doping-bypantani-ullrich-in-1998/2582769/ (reporting that seven teams withdrew or were
ejected from the Tour in 1998 after the doping probe and that the 1997 Tour winner
admitted to doping); see also Who We Are, WORLD ANTI-DOPING AGENCY, supra
note 8 (stating that the creation of WADA in 1999 was a direct response to the
doping scandal in cycling).
25. See World Anti-Doping Code, supra note 9, at 11 (suggesting that the Code’s
unified approach was addressing problems created from uncoordinated anti-doping
efforts).
26. See id. (stating that supporting an athlete’s natural talent is the underlying
rationale for the spirit of sport).
27. Id.
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In other words, the purpose of the Code is to ensure every athlete
has a fair and equal chance at success by prohibiting doping substances
and methods.28 Safeguarding the health of athletes is also important to
ensuring fair competition under the Code.29
Additionally, the Code has six international standards that aim for
consistency among anti-doping organizations, including a List of
Prohibited Substances and Methods.30 A substance or method becomes
prohibited— or amounts to the level of being prohibited— by meeting
at least two of the following: (1) The substance has the potential to
enhance or enhances sport performance; (2) the substance represents
an actual or potential health risk to the athlete; and (3) the substance
violates the spirit of sport.31 First, a substance has the potential to
enhance sport performance when the substance artificially alters an
athlete’s body by increasing his or her athletic ability in such a way
that he or she could not otherwise do.32 Second, a substance presents
potential health risks to an athlete when the use or method of use
unnecessarily threatens the athlete’s health in ways that would not
exist except for the use of the substance.33 Third, a substance violates
the spirit of sport by undermining at least one of the eleven
characteristics encompassed within the spirit of sport, including the
safeguarding of health, ethics, and fair play within sports
28. Id.
29. See id. at 14 (providing that health of the athlete is one of the foundational
rationales for heightened doping regulation).
30. See id. at 12, 29–31 (identifying the six international standards as Testing,
Laboratories, Therapeutic Use Exemptions (TUEs), the Protection of Privacy and
Personal Information, Code Compliance by Signatories, and the Prohibited List, and
indicating that the prohibited list is non-exhaustive and includes both substances and
methods prohibited at all times or in-competition only).
31. See id. at 14 (defining the fundamental rationale for the spirit of sport as the
“essence of Olympism [and] the pursuit of human excellence through the dedicated
perfection of each person’s natural talents”).
32. See id. at 14 (relying on medical and scientific evidence to label a substance
as prohibited); see, e.g., Prohibited List, supra note 10 (prohibiting anabolic
androgenic steroids, diuretics and masking agents, gene doping, and in-competition
stimulants).
33. Id. at 30; see, e.g., Performance-enhancing Drugs: Know the Risks, MAYO
CLINIC, https://www.mayoclinic.org/healthy-lifestyle/fitness/in-depth/performanceenhancing-drugs/art-20046134 (last visited Sept. 21, 2019) (including high blood
pressure, psychiatric disorders, liver abnormalities, increased risk of tendon rupture,
and heart problems as risks of using anabolic steroids).
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competitions.34
A sport’s organization becomes a signatory to the Code by adhering
to the three-step process of acceptance, implementation, and
enforcement.35 A signatory is responsible for implementing
regulations that align with the Code and for reporting accurate
information when requested by WADA.36
ii. World Athletics
World Athletics was originally founded as the world’s governing
authority for track and field athletes to create standardized technical
equipment and to keep an official list of world athletic records.37 In an
effort to become more proactive, World Athletics adapted its role to
ensure that the maximum number of people can compete and
participate in track and field.38
Within its governing authority, World Athletics sets regulations and
guidelines that athletes must adhere to in order to compete in events
sanctioned by World Athletics.39 Additionally, World Athletics has
34. See World Anti-Doping Code, supra note 9, at 14 (distinguishing the
characteristic of health from ethics and fair play).
35. See Code Compliance by Signatories, WORLD ANTI-DOPING AGENCY, 23–
28
(2018),
https://www.wadaama.org/sites/default/files/resources/files/isccs_april_2018_0.pdf (explaining that a
signatory must sign a declaration of acceptance and then implement the Code by
enacting Code provisions through policies, statutes, rules, or regulations).
36. See id. at 30–40, 44–55 (providing that a signatory must be able to explain
any actions taken to correct alleged non-conformities and establishing a six-step
process for non-compliant, or allegedly non-compliant, signatories to fall back into
compliance with the Code); see also World Anti-Doping Code, supra note 9, at 125
(referring signatories to the process stated in the International Standard of Code
Compliance).
37. See About World Athletics, supra note 1 (noting that IAAF was originally
named the International Amateur Athletic Federation and later changed its name in
2001 to reflect the political and socio-economic changes and growth of professional
sports).
38. See id. (explaining that the IAAF hosts its World Championship every two
years and claiming only the Olympic Games and the FIFA World Cup are larger
than the IAAF World Championships in terms of global reach).
39. See Constitution, WORLD ATHLETICS, 1, 48 (Nov. 1, 2019) [hereinafter IAAF
Constitution], https://worldathletics.org/download/download?filename=5de179865ed9-4b70-a761-164e35e52062.pdf&urlslug=2017%20IAAF%20Constitution
(including the IAAF’s own anti-doping rules in the most recent version); see
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enacted its own constitution that specifies the roles and purposes of
the organization and the rights of the athletes that World Athletics has
agreed to recognize.40 The constitution is intended to preserve the right
of every athlete to participate without “unlawful discrimination of any
kind”.41 Moreover, if any athlete wants to challenge a regulation or
action by World Athletics, the athlete can file the dispute with CAS.42
iii. The Court of Arbitration for Sport
CAS officially came into force in 1984, creating a more flexible,
quick, and inexpensive procedure for sports disputes.43 CAS is
responsible for hearing two types of disputes: disputes of a
commercial nature (e.g., contracts, sponsorships, civil liability issues)
and disputes of a disciplinary nature (e.g., doping issues, violence on
the field, abuse of referees).44 CAS is further divided into the Ordinary
Arbitration Division and the Appeals Arbitration Division.45

B. THE ROAD TO ENACTMENT
Traditionally sports competitions divide events between male and
female, so that males are competing against males and females against
females.46 This divide is based on the original idea that sex was binary,
generally Anti-Doping Rules, WORLD ATHLETICS (Nov. 1, 2019),
https://www.worldathletics.org/about-iaaf/documents/book-of-rules.
40. See generally IAAF Constitution, supra note 39.
41. Id. at 1–2.
42. See id. at 54 (detailing the dispute process for athletes to use in response to
World Athletics decisions).
43. See History of the CAS, supra note 23 (defining CAS as “an arbitral
jurisdiction devoted to resolving disputes directly or indirectly related to
international sport” and explaining the International Council of Arbitration for Sport
was created to safeguard the independence of CAS and the rights of the parties by
looking after the administration and financing of CAS).
44. See id. (explaining that the Code of Sports-Related Arbitration governs CAS
arbitration and that the Code is divided into statutes of bodies working for the
settlement of sports-related disputes, procedural rules, and optional mediation rules).
45. See id. (detailing that the Ordinary Division hears sole-instance disputes
submitted to CAS and the Appeals Division hears disputes resulting from finalinstance decisions made by sports organizations and noting that CAS is made up of
sixty arbitrators appointed by the IOC, the IOC President, and the National Olympic
Committees).
46. See Michele Krech, To Be a Woman in the World of Sport: Global
Regulation of the Gender Binary in Elite Athletics, 35 BERKELEY J. INT’L L. 262,
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but as time has passed and science has advanced it is now generally
accepted that sex is on a spectrum.47 The notion of a sex spectrum has
called sports competitions to question what category intersex athletes
should participate.48 The alleged threat to fair competition posed by
intersex athletes is not a new phenomenon.49 A look into the history of
sex verification testing will illuminate how World Athletics’ new
regulations came to fruition.50
i. The History of Sex Verification Testing
Under the belief that males and females ought to compete
separately, sex verification tests originated during the 1936 Berlin
Olympic Games when rumors suggested male athletes were posing as
female athletes.51 Helens Stephens, a sprinter for the United States,
264–66 (2017) (detailing the history of the binary classification and explaining that
the purpose of the division was to create a level playing field at the benefit of female
athletes); see also Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v.
IAAF, CAS 2018/0/5798, 118–19 (2019) (describing the need to create a protected
class of females for the benefit of all athletes in the administration of athletics).
47. See Krech, supra note 46, at 269–70 (describing “sex on a spectrum” as
consisting of overlapping characteristics between males and females and that at least
ten characteristics have been identified as indicators of sex); see, e.g., Gender
Revolution: Special Issue on the Shifting Landscape of Gender, NAT’L GEOGRAPHIC
(Jan. 2017) (featuring a discussion guide for teachers and parents on the shifting
landscape of gender).
48. See Anna Peterson, Comment, But She Doesn’t Run Like a Girl: The Ethic
of Fair Play and the Flexibility of the Binary Conception of Sex, 19 TUL. J. INT’L &
COMP. L. 315, 316 (2010) (analyzing IAAF’s sex-verification testing when suspicion
was first raised regarding the sex of Caster Semenya); see also Annie Bach Yen
Nguyen, Fairness at a Price: Protecting the Integrity of Athletic Competitions at the
Expense of Female Athletes, 8 NOTRE DAME J. INT’L & COMP. L. 54, 55–56 (2018)
(analyzing how the IOC struggles with defining intersex athletes within the binary
classification in relation to the suspicion of Dutee Chand’s sex).
49. See Isaac Eger, In the 1930s, Intersex Athletes Worried Olympic Officials
About the Future of Women’s Sports, TIMELINE (Mar. 14, 2017),
https://timeline.com/intersex-athletes-olympic-test-5613d99f24dc (describing how
the concern of intersex athletes competing against non-intersex female athletes dates
back to the 1930s).
50. See Ruth Padawer, The Humiliating Practice of Sex-Testing Female Athletes,
N.Y. TIMES (June 28, 2016), https://www.nytimes.com/2016/07/03/magazine/thehumiliating-practice-of-sex-testing-female-athletes.html (explaining the history of
sex verification tests in light of Dutee Chand’s sex being called into question).
51. Jessica L. Adair, In a League of Their Own: The Case for Intersex Athletes,
18 SPORTS L.J. 121, 132–37 (2011) (depicting how the sex verification test
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was first accused of being a male after winning gold for the 100m
sprint and for having perceived masculine features.52 Due to the
allegations, Stephens underwent a physical examination to confirm
that she was in fact biologically female.53 Additionally, following the
1936 Olympics, rumors began to spread of male athletes posing as
females in the female classification causing the IOC to impose
physical examinations of female athletes.54 The examinations, also
known as the “nude parades,” consisted of female athletes lining up
and undressing while an all-male committee examined the athletes’
genitals to ensure that they were females.55
In response to protests by athletes, the IOC replaced the nude
parades with the Barr Body Test that tested athletes’ chromosomes via
a swab of the inside of the mouth.56 The Barr test determined an athlete
was female by identifying a chromatin clump that is only present in
cells with XX chromosomes.57 Eva Kloblukowska, a sprinter from
Poland, became the first athlete disqualified because her chromosomes
resulted in XX/XXY and therefore failed the Barr test.58 After being
disqualified for not being biologically female, Klobukowska gave
birth to her first child bringing the Barr test into question.59 As
originated).
52. See id. at 132–33 (noting a fellow American sprinter, Stella Walsh, accused
Stephens after Walsh lost to Stephens in the 100m event).
53. See id. (explaining that the examination used did not establish whether an
athlete has a specific disorder of sex development).
54. See id. at 133–34 (describing the IOC’s initiation of the examinations in
response to media reports of male athletes binding their genitals to compete against
women).
55. See id. at 133 (suggesting the nude parades were validated when two Russian
athletes, who received particularly harsh criticism, refused to compete after the sex
verification procedures were implemented); see also Peter Donnelly & Michele K.
Donnelly, University of Toronto Centre for Sport Policy Studies Research Reports,
Sex Testing, Naked Inspections and the Olympic Games, 4 (2013),
https://kpe.utoronto.ca/sites/default/files/donnelly-donnelly-sex-testing-nakedinspections-the-olympic-games.pdf (noting that no male imposters were identified
while some female athletes were excluded for not appearing feminine enough).
56. Adair, supra note 51, at 133–34 (describing the Barr test procedure which
was used to determine an athlete’s femininity).
57. See id. (indicating athletes who tested negative for the chromatin clump still
had to undergo a physical examination).
58. Id. at 135–37 (elaborating that Kloblukowska was stripped of her medals
when she failed the Barr test).
59. Id. (maintaining that the ability to give birth is a stronger indicator of sex
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technology advanced, the Barr test was replaced with the Polymerase
Chain Reaction test (PCR) that detected the Y chromosome; any
athlete who tested positive was then classified as male.60 Although
World Athletics stopped mandatory sex verification testing in 1991,
sex verification tests can be compelled when an athlete’s biological
sex is questioned.61
ii. World Athletics Enacts New DSD Regulations
In 2014, World Athletics enacted Regulations Governing Eligibility
of Females with Hyperandrogenism to Compete in Women’s
Competition
(Hyperandrogenism
Regulations).62
The
Hyperandrogenism Regulations required female athletes to reduce
their naturally produced levels of testosterone by consuming oral
contraceptives.63 The regulations applied to all female athletes
competing in any track and field event.64
Dutee Chand, a hyperandrogenic female sprinter from India,
challenged World Athletics’ regulations in CAS arbitration and argued
that the regulations were unfairly discriminatory, disproportionate,
based on insufficient scientific evidence, and an impermissible doping
than chromosomes).
60. See, e.g., id. at 132–37 (explaining how the P.C.R. test caused false positives
in female athletes who had the Y chromosome, usually caused by their intersex
condition, and detailing the increased criticism of the P.C.R. test after one of the
DNA markers was found in both males and females).
61. Id. at 134–37 (noting that sex testing may be required when an official
believes an investigation is warranted, which initiated the public scrutiny of Caster
Semenya’s sex).
62. See Dutee Chand v. Athletics Federation of India [AFI] & International
Association of Athletics Federations [IAAF], CAS 2014/A/3759, 71, 71-72 (Court
of
Arbitration
for
Sport,
July
24,
2015),
https://www.tascas.org/fileadmin/user_upload/Bulletin_2015_2_internet_.pdf (explaining IAAF’s
Hyperandrogenism Regulations enacted in 2014); see also Hyperandrogenism
Explained and What it Means for Athletes, USA TODAY (Aug. 2, 2016),
https://www.usatoday.com/story/sports/olympics/2016/08/02/hyperandrogenismexplained-and-what-it-means-for-athletics/87944968/
(explaining
Hyperandrogenism as a medical condition where an individual produces an excess
of hormones, and one that comes in many forms, including intersex females who
produce higher levels of testosterone).
63. See Dutee Chand v. AFI & IAAF, CAS 2014/A/3759, 14-25 (2015)
(explaining that contraceptives are testosterone-suppressing).
64. Id.
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sanction in violation of the Code.65 CAS favored Chand in holding that
World Athletics failed to show how the regulations were necessary,
and made use of reasonable and proportional means.66 However, CAS
allowed World Athletics two years to provide specific evidence that
might support requiring female intersex athletes to artificially reduce
their testosterone level.67
Following the CAS award for Chand, World Athletics tested
twenty-one events and ranked them based on how strong the
correlation of a higher testosterone level impacted athletic
performance.68 After two years, World Athletics replaced the
Hyperandrogenism Regulations with the Eligibility Regulations for
the Female Classification (Athletes with Differences of Sex
Development) (DSD Regulations).69 The DSD Regulations, similar to
the Hyperandrogenism Regulations, required female athletes to take
oral contraceptives to reduce their testosterone levels.70 Differences of
sex development is defined as the “congenital conditions that cause
atypical development of an individual’s chromosomal, gonadal,
65. See id. at 34–36, 104–06 (arguing the Hyperandrogenism Regulations
violated the Code’s criteria of a prohibited substance under Article 4.3 and failing to
implement regulations that align with the Code under Article 23); see also Athletes
Profiles:
Dutee
Chand,
WORLD
ATHLETICS,
https://www.worldathletics.org/athletes/india/dutee-chand-275950 (last visited Dec.
17, 2019) (listing Dutee Chand’s events, rankings, personal bests, and other
statistics).
66. See Dutee Chand v. AFI & IAAF, CAS 2014/A/3759, 146-56 (2015),
(explaining that there was insufficient evidence to support IAAF’s claim that female
intersex athletes enjoy a similar advantage as male athletes do over non-intersex
female athletes).
67. See id. at 158 (suspending the Hyperandrogenism Regulations but allowing
the IAAF to submit supplemental evidence that Chand would need to challenge to
maintain the suspension of the regulations).
68. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 12, 18, 29–32, 53 (2019) (noting the IAAF only tested samples
collected from athletes during regular doping tests and did not inform athletes of
what their samples were being used for, and disclosing that the IAAF only randomly
tested three athletes, including Semenya, who underwent testosterone-suppressing
treatment without considering how testosterone levels increase when an athlete is at
rest or doing light training).
69. See generally Eligibility Regulations for the Female Classification, supra
note 2 (noting this is Version 2.0 of the regulations that came into effect on May 8,
2019).
70. See id. at 2–4 (mentioning surgery is not required in any circumstances).
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and/or anatomic sex.”71 The DSD Regulations, therefore, only apply
to female athletes who meet the standard of a Relevant Athlete72 as
defined in the regulations.73 A Relevant Athlete complies with the DSD
Regulations by undergoing oral contraceptive treatment that reduces
her blood testosterone level to below five (5) nmol/L for a continuous
period of at least six months prior to competing in one of the restricted
events.74 The athlete must maintain a testosterone level below five (5)
nmol/L to remain eligible to compete in the female classification of
the restricted events.75 The oral contraceptive treatment entails
multiple doses a day with consistent monitoring and management of
side effects by a physician.76 Athletes are also financially responsible
for their treatment.77
Additionally, the DSD Regulations only restrict specific track and
field events, unlike the Hyperandrogenism Regulations that applied to

71. Id. at 1 (including intersex female athletes who have 46 XY chromosomes
and produce a higher level of testosterone than the average female range).
72. See id. (describing the “Relevant Athlete” as someone who, as a result of her
genetic make-up, has “circulating testosterone levels in [her] blood of five (5)
nmol/L or above and [has] sufficient androgen sensitivity for those levels of
testosterone to have a material androgenising effect”).
73. Id. (excluding female athletes with XX chromosomes and male athletes from
the regulations).
74. Id. But see Katrina Karkazis & Morgan Carpenter, Impossible “Choices”:
The Inherent Harms of Regulating Women’s Testosterone in Sport, J. BIOETHICAL
INQUIRY 581–85 (2018) (arguing athletes do not have an independent, voluntary
choice when they are forced to consider the external influence of remaining eligible
to compete).
75. Eligibility Regulations for the Female Classification, supra note 2, at 3; see
Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS
2018/0/5798, 12 (2019) (including decreased bone mineral density, weight gain,
hypotension, renal dysfunction, electrolyte abnormalities, and nausea as physical
side effects of the treatment); see also id. at 53–56 (2019) (including ASA’s claim
that inspections of the athlete’s bodies will continue because there is no means of
testing an athlete’s androgen receptor sensitivity, which is responsible for the
production of higher testosterone levels).
76. See Rebecca Jordan-Young, et al., Sex, Health, and Athletes, BRITISH MED.
J. 2–3 (Apr. 28, 2014) (explaining long term use of the oral contraceptives can be
costly and can negatively impact an athlete’s physical functioning and fertility
goals).
77. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 158 (2019) (suggesting an athlete may have to absorb the cost of
monitoring her testosterone); see also Jordan-Young, supra note 76, at 2–3.
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all events.78 The restricted events include 400m races, 400m hurdles
races, 800m races, 1500m races, one-mile races, and all other track
events with distances between 400m and one mile (inclusive).79
During testing, the restricted events ranked second, fifth, sixth, and
tenth for the largest correlations between athletic performance and
testosterone.80
iii. Caster Semenya Challenges New DSD Regulations
Elite middle-distance runner, Caster Semenya, and the ASA
challenged the DSD Regulations in CAS arbitration.81 Semenya and
ASA argued that the DSD Regulations were unfairly discriminatory,
arbitrary and disproportionate, an infringement of universally
recognized fundamental human rights, and violative of World
Athletics’ Constitution.82 On the other hand, World Athletics argued
78. See Eligibility Regulations for the Female Classification, supra note 2, art.
2.2(b) (applying the regulations to intersex female athletes competing alone, as part
of a relay event, or as a Combined Event).
79. Id.; see Infra Part II(ii) (explaining the testing and research that the IAAF
used in support of restricting specific events).
80. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 155–56 (2019) (recommending the 1500m and one-mile events
be removed from the restricted events because the IAAF questionably assumed that
since athletes who perform well in the 800m event often compete successfully in the
longer events, then intersex athletes must enjoy the same advantage competing in
the 1500m and one-mile events). But see Semenya v. IAAF, CAS 2018/0/5794 &
Athletics South Africa v. IAAF, CAS 2018/0/5798, 148 (2019) (recognizing
Semenya’s fastest time in the 800m has been beaten by almost 3,000 men, that she
is consistently between 9% and 14% slower than the performance of comparable
men, and that on average she finishes ahead of second place by 1.03%, which is
significantly lower than the average male who finishes 10-12% faster than the
average female).
81. See Athlete Profile: Caster Semenya, supra note 4 (providing Caster
Semenya’s athletic statistics and events she has won, including first place in the
800m sprint in both the 2012 and 2016 Olympics); see also Guy Davies, Female
Track Star Caster Semenya in Court to Challenge Gender Ruling in Landmark Case
on
Testosterone
Levels,
ABC
NEWS
(Feb.
18,
2019),
https://abcnews.go.com/International/track-star-caster-semenya-court-challengegender-ruling/story?id=61146255 (reporting Semenya’s official filing to CAS to
challenge the regulations).
82. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
45–47, 142 (2019) (noting Semenya and ASA also argued the regulations violated
the Olympic Charter, Laws of Monaco, and laws of jurisdictions in which
international athletics competitions are held, and summarizing the Human Rights
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that the DSD Regulations are necessary and make use of reasonable
and proportionate means for safeguarding fair competition and
competition on a level playing field.83
On April 30, 2019, CAS upheld World Athletics’ DSD Regulations
and stated that although the regulations are discriminatory, the
regulations are necessary and make use of reasonable, proportional
means to achieve fair competition.84 CAS accepted Semenya’s
discrimination argument and held that the DSD Regulations are prima
facie discriminatory because they impose differential treatment on an
immutable characteristic of a select group of athletes who participate
in certain events without a comparable regulation for athletes
competing in unrestricted events.85 The burden then shifted to World
Athletics to prove the regulations were necessary, reasonable, and
proportional for the goal intended.86 CAS accepted World Athletics’
necessity claim that splitting events between males and females is
based on human biology and allowing females to compete with levels
of testosterone that are within the male range is unfair to women who
cannot naturally produce that level of testosterone.87 CAS further
accepted that requiring athletes to undergo testosterone-suppressing
Watch’s testimony claiming that the regulations violate athletes’ fundamental rights
to privacy and to control what goes into their bodies); see generally Human Rights
Council, Elimination of Discrimination Against Women and Girls in Sport, U.N.
Doc. A/HRC/40/L.10/Rev.1 (Mar. 20, 2019) (featuring a resolution condemning the
DSD Regulations).
83. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
71–79, 152–54 (2019) (arguing that the higher percentage of intersex athletes in elite
sports than the percentage of intersex athletes in the general population is evidence
of the advantage intersex athletes have over non-intersex female athletes, and
holding that the oral contraceptives are reasonable because surgery is more
intrusive).
84. Id. at 142–60 (holding the side effects affecting individual athletes did not
outweigh IAAF’s goal of protecting the female classification).
85. See id. at 142–44 (excluding non-intersex female athletes, intersex female
athletes only competing in unrestricted events, and all male athletes).
86. See id. at 144 (“[I]t is common ground that a rule [imposing] differential
treatment on the basis of a particular protected characteristic is valid and lawful if it
is a necessary, reasonable and proportionate means of attaining a legitimate
objective.”).
87. See CAS Executive Summary, supra note 5, at 5 (explaining that it is
“category defeating” to permit athletes with testosterone-derived advantage to
compete in a category that is meant to exclude athletes with the testosterone-derived
advantage).
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treatment is reasonable and proportional to achieving fair competition
in the female classification.88
Additionally, as the CAS panel explained, the tension between
every athlete’s right to compete in sport without sex discrimination
and the right of female athletes to compete against other female
athletes to achieve athletic success was at the heart of Semenya’s
challenge.89 CAS further suggested its decision was “constrained by
the accepted [binary] division of athletes . . . when there is no such
binary division.”90 Since the binary division was not challenged, the
CAS panel suggested its decision was restricted by the binary
framework.91 CAS, however, did raise potential concerns of
compliance and the possibility of affected athletes being unable to
consistently maintain, at no fault of their own, a testosterone level
below 5 nmol/L.92 CAS warned that World Athletics may have to
address these concerns among any other unexpected effects in
enforcing the regulations.93
Following the CAS decision, Semenya and ASA filed an appeal on
May 29, 2019 to the Swiss Federal Tribunal.94 The Tribunal originally
88. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 151–60 (2019) (explaining that since the panel found the
regulations were necessary, it must follow that, for the same reasons, the regulations
are reasonably connected to the objective of fair competition).
89. See id. at 120 (suggesting that female athletes would not be able to achieve
the same success competing against males as they do against other females).
90. CAS Executive Summary, supra note 5, at 3.
91. Id. (explaining CAS’s authority is to review the regulations in light of the
parities challenges and arguments).
92. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 157, 159 (warning that if the IAAF cannot implement the DSD
Regulations fairly in practice that could render the regulations disproportionate).
93. See id. at 160 (clarifying that the DSD Regulations is a living document).
94. See Loi fédérale sur le droit international privé, 18 Dec 1987 (RS 291)
(applying jurisdiction over CAS arbitrations because the Swiss Federal Tribunal has
the authority to hear all appeals from arbitrations with a legal seat in Switzerland’s
arbitral tribunal); see also History of the CAS, supra note 23 (stating that CAS’s
legal seat is in Lausanne, Switzerland); ‘The IAAF Will Not Drug Me or Stop Me
Being Who I Am’: Semenya Appeals Cas Ruling, THE GUARDIAN (May 29, 2019),
https://www.theguardian.com/sport/2019/may/29/caster-semenya-appeals-againstcas-ruling-over-iaaf-s-testosterone-levels (quoting Semenya after she filed her
appeal); Semenya Appeals Against Testosterone Ruling, ASSOCIATED PRESS (May
29,
2019),
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permitted Semenya to compete without taking the required oral
contraceptives in World Athletics’ upcoming World Championship;
however, the Tribunal has since reversed its decision making Semenya
ineligible to defend her title in the 800m event.95
iv. World Medical Association Opposes DSD Regulations
In April of 2019, prior to the CAS ruling, the World Medical
Association (WMA) called for World Athletics to immediately
withdraw the new DSD Regulations and urged physicians to not
implement the new World Athletics rules.96 In its letter, the WMA
expressed concerns of requiring athletes to take “unjustified
medication,” or medication for a reason other than to treat a medical
condition.97 WMA President Dr. Leonid Eidelman further stated
ethical reservations about requiring physicians to prescribe the oral
contraceptives to athletes for a non-pathological reason.98 In a
response letter, World Athletics addressed WMA’s ethical concerns
by claiming that the oral contraceptive is a recognized standard of care
http://www.espn.com/olympics/trackandfield/story/_/id/26848060/semenyaappeals-testosterone-ruling (reporting Semenya’s appeal).
95. Compare Caster Semenya: Swiss Court Rejects IAAF Request to Re-Impose
Testosterone
Rules,
BBC
SPORT
(June
13,
2019),
https://www.bbc.com/sport/athletics/48630087 (stating the Swiss Federal Tribunal
denied IAAF’s request for Semenya to follow the regulations during the appeal
process), with Jeré Longman, Caster Semenya Barred From 800 Meters at World
Championships,
N.Y.
TIMES
(July
30,
2019),
https://www.nytimes.com/2019/07/30/sports/caster-semenya-worldchampionships.html (explaining the decision was reversed because Semenya failed
to “meet the ‘strict requirements and high thresholds’ necessary to continue the
interim suspension”).
96. See WMA Urges Physicians Not to Implement IAAF Rules on Classifying
Women Athletes, WORLD MED. ASS’N NEWS & PRESS (Apr. 25, 2019),
https://www.wma.net/news-post/wma-urges-physicians-not-to-implement-iaafrules-on-classifying-women-athletes/ [hereinafter WMA Initial Letter to IAAF]
(noting the WMA’s recommendation followed an initiative by the South African
Medical Association); see also About Us, WORLD MED. ASS’N,
https://www.wma.net/who-we-are/about-us/ (last visited Aug. 11, 2019) (explaining
WMA is an international organization that represents physicians and ensures the
highest possible standards of ethical behavior and care by physicians).
97. WMA Initial Letter to IAAF, supra note 96 (stating that the regulations are
“contrary to a number of key WMA ethical statements and declarations”).
98. See id. (urging doctors not to prescribe the oral contraceptives without a
medical reason).
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for 46XY DSD athletes and that the athletes ultimately make the
decision themselves whether or not to take the medication.99 Although
athletes who choose not to take oral contraceptives cannot compete in
international competitions, World Athletics explained that they are not
completely restricted from competing in any competition or an
unrestricted event.100
In response, the WMA reaffirmed its opposition to the DSD
Regulations in another letter to World Athletics.101 WMA asserted a
legitimate medical need is the only justification for a medical
treatment and reducing testosterone to maintain an athlete’s eligibility
to compete does not amount to a medical need.102 Likewise, the WMA
claimed that medical treatment for the “sole purpose of altering
performance in a sport is not permissible” and violates the ethical duty
of physicians.103

C. TRANSGENDER ATHLETES INCLUDED IN INTERNATIONAL
SPORTS COMPETITIONS
Transgender athletes are required to take particular medications and
hormonal treatment for their transition to be effective.104 Various
99. See IAAF Letter to the World Medical Association, INT’L ASS’N ATHLETICS
FED’NS NEWS (May 7, 2019) [hereinafter IAAF Letter to WMA],
https://www.iaaf.org/news/press-release/iaaf-letter-wma
(suggesting
the
medications are also gender-affirming for 46XY DSD athletes who choose to
identify as a female).
100. See id. (suggesting athletes can participate in (1) the female classification in
any non-international competition or unrestricted events at international
competitions; (2) the male classification at any competition level; and (3) any
‘intersex’ classification that a competition may offer).
101. See Physician Leaders Reaffirm Opposition to IAAF Rules, WORLD MED.
ASS’N NEWS & PRESS (May 15, 2019) [hereinafter WMA Response Letter],
https://www.wma.net/news-post/physician-leaders-reaffirm-opposition-to-iaafrules/ (rejecting IAAF’s explanations for why the oral contraceptives are ethical to
prescribe).
102. Id. (“The mere existence of an intersex condition, without the person
indicating suffering and expressing the desire for an adequate treatment, does not
constitute a medical indication.”).
103. Id. (arguing it is unethical for a physician to prescribe treatment when there
is nothing to treat).
104. See, e.g., The Medical Care of Transgender Persons, FENWAY HEALTH, 11
(2015) (explaining hormone treatment regimens, such as testosterone cypionate or
long-acting injectable testosterone undecanoate for a male to female transition).

550

AM. U. INT’L L. REV.

[35:3

national and international sports organizations are adapting their
policies to allow transgender athletes to compete without violating any
anti-doping regulations.105 For instance, the Canadian Centre for
Ethics in Sport changed its anti-doping policies to accommodate
female-born athletes who transition to males and have to take artificial
testosterone.106 Similarly, the National Collegiate Athletic Association
(NCAA) (governing authority for college sports in the United States)
implemented an Inclusion of Transgender policy allowing transgender
athletes to compete so long as the athletes provide notice of the
treatment and ongoing monitoring to the NCAA.107
On the international scale, both the IOC and World Athletics have
taken steps to include transgender athletes in competitions.108 The IOC
enacted the world’s first policy for transgender inclusion, which
permitted a transgender athlete to compete in the Olympics only if (1)
the athlete’s surgery was completed, (2) the athlete’s relevant national
authorities recognized his or her legal status, and (3) the athlete had

105. See Rachel Corbett, Gender Identity and Sport, 37 LAWNOW 38, 41–42
(2012) (referring to sport organizations across the world that have acted upon
transgender inclusion).
106. See id. at 42 (explaining that granting therapeutic use exemptions (T.U.E.)
has been broadened to include treatments for transgender athletes within the
Canadian Collegiate Athletic Association); see also Creating Inclusive
Environments for Trans Participants in Canadian Sport – Policy and Practice
Template for Sport Organizations, CANADIAN CENTRE FOR ETHICS IN SPORT 5–21
(2018),
https://cces.ca/sites/default/files/content/docs/pdf/creating_inclusive_environments
_for_trans_participants_in_canadian_sport_practice_and_policy_template_final_e.
pdf (establishing a guiding policy for Canadian sport organizations to adopt and
implement).
107. See NCAA Policy on Transgender Student-Athlete Participation, NCAA, 1214
(Aug.
2011),
https://www.ncaa.org/sites/default/files/Transgender_Handbook_2011_Final.pdf
(recommending policies for student athletics programs to implement in furtherance
of the NCAA’s goal of transgender inclusion).
108. Compare IOC Medical Commission, Stockholm Consensus (Dec. 11, 2003)
(recommending the IOC Executive Committee adopt sex reassignment regulations),
with IAAF Regulations Governing Eligibility of Athletes Who Have Undergone Sex
Reassignment to Compete in Women’s Competition, IAAF 1 (May 1, 2011)
[hereinafter Sex Reassignment Regulations] (allowing a male-born athlete who
transitions to female to compete in the female classification once “her case has been
evaluated by the IAAF in accordance with these Regulations”).
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hormonal treatment for a minimum of two years.109 Along the same
lines, World Athletics enacted sex reassignment regulations in 2011
to allow male-born athletes who have become female to compete in
the female classification.110 Affected athletes must notify World
Athletics at least three months prior to the relevant competition and
are required to get approval from World Athletics’ Medical
Manager.111 However, the regulations do not specify the maximum
testosterone level and do not require the athlete’s testosterone to be
below a certain level for a specified time period prior to competing.112

D. CAS PERMITS AMPUTEE TO COMPETE WITH ARTIFICIAL LEGS
South African sprint runner, Oscar Pistorius, became the first
amputee to compete in track events in the Olympic Games.113 Pistorius
was born with missing fibulas that led to the amputation of both his
legs below the knee prior to his eleventh birthday.114 Pistorius went on
to win the Gold Medal in the 2004 Athens Paralympics for the 200m
event, then started competing in World Athletics-sanctioned events
against “able-bodied” athletes.115 The World Athletics Council
adopted a rule regulating the use of technical devices in competitions,
which led to World Athletics declaring Pistorius ineligible to compete
in World Athletics-sanctioned events because his artificial legs gave
109. See Stockholm Consensus, supra note 108; see also IOC Approves
Consensus with Regard to Athletes Who Have Changed Sex, INT’L OLYMPIC
COMMITTEE NEWS (May 17, 2004), https://www.olympic.org/news/ioc-approvesconsensus-with-regard-to-athletes-who-have-changed-sex (noting the IOC
Executive Committee implemented the Medical Commission’s Stockholm
Consensus recommendation).
110. See Sex Reassignment Regulations, supra note 108, at 1.4 (noting femaleborn athletes who become male do not have comparable regulations).
111. See id. at 2.1, 6.1-6.6 (stating the athlete’s blood-testosterone level is
analyzed in the endocrine assessment).
112. See Sex Reassignment Regulations, supra note 108, at 4.1-5.2. But see
Eligibility Regulations for the Female Classification, supra note 2, at 2.3(b-c)
(establishing the testosterone threshold and length of time necessary for intersex
athletes).
113. See Pistorius v. IAAF, CAS 2008/A/1480, 1 (2008) (presenting each party at
the beginning of the CAS award for Oscar Pistorius).
114. See id. (noting Pistorius’s condition was naturally produced).
115. See
id.
at
2;
see
also
Oscar
Pistorius,
BIOGRAPHY,
https://www.biography.com/athlete/oscar-pistorius (last visited Aug. 11, 2019)
(mentioning that his win in Athens is where he got the nickname “Blade Runner”).
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him an unfair advantage over the “able-bodied” athletes.116
In 2008, Pistorius challenged the World Athletics’ decision in CAS
arbitration.117 The CAS panel found that Pistorius did not gain an
“overall net advantage” over the other athletes even though he was
able to run at his max in the last half of his race rather than at the
beginning as the able-bodied runners did.118 Thus, Pistorius’s artificial
legs did not amount to a total advantage under the rule overturning
World Athletics’ decision to exclude Pistorius from the Olympic
Games.119

III. ANALYSIS
World Athletics’ new DSD Regulations violate the Code by
limiting the natural abilities of female athletes with higher levels of
testosterone from competing in restricted events in the name of
creating “fair competition.” 120 For a substance to be prohibited under
the Code, the substance must meet at least two of the three criteria: the
substance must not (1) artificially enhance sport performance, (2) pose
unnecessary health risks to the athlete, or (3) violate the spirit of
sport.121 World Athletics’ pursuit to create fair competition is blinded
and severely restricted by the binary framework of sex classifications
at the expense of the athletes’ health and the spirit of sport.122 The DSD
116. See Pistorius v. IAAF, CAS 2008/A/1480, 3-5 (2008) (prohibiting the “use
of any technical device that incorporates springs, wheels or any other element that
provides the user with an advantage over another athlete not using such a device,”
and summarizing IAAF’s assertion that the energy loss from using artificial legs was
significantly lower than the energy loss from a human ankle joint running at sprint
speed).
117. See id. at 1, 11 (explaining IAAF had the burden of proof under the “balance
of probability standard”).
118. See id. at 11-14 (explaining how an unfair advantage will undermine fair play
in competitions).
119. See id. at 11–14; see also Oscar Pistorius, supra note 115 (recording
Pistorius “made history in 2012 as the first amputee to compete in track events at the
Olympics”).
120. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 9-71 (2019) (summarizing evidence and arguments presented by
Semenya and the ASA); see generally World Anti-Doping Code, supra note 9
(supporting the notion of fair competition through anti-doping regulations).
121. World Anti-Doping Code, supra note 9, at 30.
122. See id. (explaining the Code’s rationale of the spirit of sport as creating a
level playing field); see also Krech, supra note 46, at 264, 276–80 (challenging
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Regulations unnecessarily threaten the health of athletes and violate
the spirit of sport by not allowing athletes to perform within their
natural abilities.123 Thus, the required oral contraceptives of the DSD
Regulations amount to a prohibited substance under the Code.124

A. THE UNNECESSARY HEALTH ALTERING MEDICAL SUBSTANCE
World Athletics’ pursuit to create fair competition is blinded by the
binary framework at the expense of a select group of female athletes’
health and well-being.125 An athlete’s health sufficiently outweighs the
goal of a level playing field, especially when doing so requires
consuming oral contraceptives without a pathological reason to do
so.126 The new DSD Regulations are both unnecessary and
disproportionate to the goal of fair competition for four reasons: (1)
The regulations place athletes and their physicians in an unethical
predicament of undergoing medical treatment without a pathological
reason, (2) CAS incorrectly narrowed the scope of potential side
effects in upholding the regulations, (3) World Athletics failed to
adequately test the impact of testosterone on athlete’s performance
before enacting the regulations, and (4) World Athletics
disproportionately focused on testosterone as the determinative factor
in athletic performance.
i. Athlete’s Health: Unethical Predicament
First, the DSD Regulations place doctors and athletes in an
unethical predicament that is both unnecessary and disproportionate to
regulations implemented by sports organizations that operate within the binary
framework without strong accountability principles and mechanisms).
123. See World Anti-Doping Code, supra note 9, at 14, 30 (stating criteria for
prohibited substances); see also infra Part III(a–b).
124. World Anti-Doping Code, supra note 9, at 30.
125. See Krech, supra note 46, at 286–94 (criticizing how the binary framework
drives rule markers to hyper focus on fair competition without considering athletes’
human rights and gender identities); see also Semenya v. IAAF, CAS 2018/0/5794
& Athletics South Africa v. IAAF, 14 (2019) (summarizing Semenya’s claim that
treatment will cause her to suffer physical side effects and “terrible psychological
harm”).
126. See WMA Initial Letter to IAAF, supra note 96 (opining that prescribing
medical treatment without a pathological reason crosses an unethical line and puts
the patient’s health at risk).
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the goal of fair competition.127 As the WMA explains, it is unethical
for a physician to prescribe treatment when the athlete does not have
a pathological condition.128 World Athletics is compelling doctors to
treat what has been arbitrarily deemed excessive testosterone for the
sole purpose of maintaining an athlete’s eligibility status.129 Although
physicians can ethically treat the excessive testosterone at the request
of the individual, athletes are requesting the treatment only because
they want to continue competing and not because they genuinely want
to reduce their testosterone levels or have a medical need to do so.130
The regulations also place athletes in the predicament of choosing the
“lesser” of two evils: (1) consume a potentially harmful substance they
do not medically need or (2) to become ineligible to compete in an
international competition.131
On the contrary, World Athletics alleges that the athletes are free to
127. See generally id. (urging doctors and physicians to refrain from
implementing the DSD Regulations by refusing to prescribe an athlete with any
medication not in accordance with their medical ethics).
128. See WMA Response Letter, supra note 101 (reaffirming in a second letter to
IAAF that the WMA stands by its prior ethical concerns and against practices that
ask physicians to take actions outside of providing medical care “in the best interest
of their patients”).
129. See WMA Initial Letter to IAAF, supra note 96 (arguing the purpose of
prescribing medical treatment for eligibility requirements contradicts the purpose of
treating pathological concerns); see also Semenya v. IAAF, CAS 2018/0/5794 &
Athletics South Africa v. IAAF, CAS 2018/0/5798, 16-19 (2019) (describing the
effects Semenya’s treatment and testimony had on her and quoting her assertion that
it was “an order by the IAAF which I had no choice but to comply with”). But see
Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS
2018/0/5798, 77-78 (2019) (summarizing IAAF’s claim that “no athlete will be
compelled to undergo any assessment or treatment . . . [and] it is the athlete’s
responsibility to decide whether to proceed with any such treatment/assessment”).
130. See WMA Response Letter, supra note 101 (asserting that it is inappropriate
to treat a patient that is not “indicating suffering and expressing the desire for an
adequate treatment”).
131. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 43-44 (2019) (quoting a clinical psychologist who stated “the
choice may not be a free one where it is the product of disadvantage and external
influence”). But see IAAF Letter to WMA, supra note 99 (reiterating that intersex
athletes can participate in events not subject to an IAAF restriction or against male
athletes in any event). See generally Eligibility Regulations for the Female
Classification, supra note 2, at 3–4 (offering intersex athletes the options to either
meet eligibility requirements by undergoing oral contraceptive treatment or choose
not compete at international competitions).
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decide, without any outside pressure influencing their decision,
whether to medically reduce their testosterone.132 As support for its
claim, World Athletics suggests athletes are not completely excluded
from competing if they choose not to undergo the necessary
treatment.133 However, World Athletics fails to recognize that
competing at international competitions is often the ultimate goal for
athletes, and those who choose not to comply with the DSD
Regulations are prohibited from competing on the international scale
within the event of their choosing.134 World Athletics also fails to
realize that athletes, like Semenya, may not want to change the events
that they have spent time and money training for, or that the athletes
might not be sufficiently competitive to compete in the unrestricted
events.135 Semenya would arguably already have been competing in
the unrestricted events if her and her trainers felt that she would
perform at the same level she performs in the 400m, 800m, or 1500m
events.136 Thus, World Athletics itself is pressuring athletes to make
an unnecessary, health-altering decision.

132. See IAAF Letter to WMA, supra note 99 (replying to WMA by claiming
affected athletes have a completely voluntary choice whether to proceed with any
assessment or treatment). But see Karkazis & Carpenter, supra note 74, at 581–85
(arguing the requirements of the eligibility regulations mean that IAAF is making
the choice for the athletes).
133. See IAAF Letter to WMA, supra note 99 (proffering other ways intersex
athletes can compete without taking the oral contraceptives, including competing in
unrestricted events at international competitions, in the male classification in any
event, or in any non-IAAF sponsored competition).
134. Compare ‘The IAAF Will Not Drug Me or Stop Me Being Who I Am’:
Semenya Appeals Cas Ruling, supra note 94 (reporting that Semenya wants to
compete as she normally does without being drugged), with IAAF Letter to WMA,
supra note 99 (claiming affected athletes are not excluded from the same
opportunities to compete as other athletes).
135. See Nguyen, supra note 48, at 65, 69–70 (highlighting that other factors,
aside from testosterone, contribute to one’s athletic success); see also Semenya v.
IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 148
(2019) (summarizing Semenya’s argument that even with a higher testosterone level
she would not be competitive against male athletes).
136. See generally Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa
v. IAAF, CAS 2018/0/5798 (2019) (suggesting that Semenya challenged the DSD
Regulations because she wants to compete in the events in which she is most
competitive).
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ii. Athlete’s Health: Side Effects
Second, World Athletics’ evaluation of how oral contraceptives will
impact an athlete’s health was too narrow in scope.137 CAS incorrectly
excluded the long-term implications of mandated oral contraceptives
on an athlete’s health, the unforeseen side effects, and how financing
the treatment can negatively impact an athlete’s well-being.138 As
presented to the CAS panel, side effects of the treatment often include
decreased bone mineral density, weight gain, hypotension, renal
dysfunction, electrolyte abnormalities, and nausea.139 By only
comparing the oral contraceptives to surgery, the invasiveness and the
increased likelihood of unexpected consequences that come with
undergoing surgery make the effects of consuming oral contraceptives
seem de minimis when, in fact, they are not.140
Long-term administration of the oral contraceptive treatment is
costly both in the amount of time and funding required.141 Since the
treatment requires multiple doses a day and consistent monitoring and
management of side effects, the affected athletes are subjected to
additional levels of stress to which other non-affected athletes are not

137. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 9-72 (2019) (summarizing expert witness testimony for Semenya
and ASA that argued the IAAF’s testing is incomplete). But see Semenya v. IAAF,
CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798 (2019) at
159 (concluding that the side effects do not outweigh the IAAF’s arguments in
support of its DSD Regulations).
138. See Krech, supra note 46, at 287–89 (implying that a financial burden is
interconnected to an athlete’s health and well-being since medical treatment requires
funding and may be difficult to obtain in some cases).
139. Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS
2018/0/5798, 16–22 (2019) (stating the opinion of Semenya’s doctor who testified
to the wide spectrum of side effects that Semenya experienced).
140. Id. at 152–54 (explaining why the CAS panel held the oral contraceptives
are less intrusive and pose less of a threat to the athletes’ health); see also Karkazis
& Carpenter, supra note 74, at 581–85 (challenging the notion that the side effects
are necessary and proportional from a medical point of view).
141. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 50–51 (2019) (quoting a Senior Advocate of India’s Supreme
Court who stated female athletes subjected to the DSD Regulations face “grave
implications” if they do not submit to testing and treatment); see also
Hyperandrogenism Explained and What it Means for Athletes, supra note 62
(explaining hyperandrogenism as a medical condition).
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exposed.142 The treatment entails extended medical care for which
World Athletics—and respective national organizations—refuse to
pay or assist athletes, resulting in more harm to athletes, especially
those of lesser financial stability.143 The DSD Regulations impose a
financial burden both while athletes are competing and after they
decide to retire from the international arena.144 Affected athletes, like
Semenya, are unfairly imperiled by this time deferring, health
hindering, and financially detrimental treatment for a natural
phenomenon of which they have no control.145
iii. Athlete’s Health: Lack of Necessary Information
Third, World Athletics’ failure to completely test how the oral
contraceptives will affect different athletes depending on their
ethnicity, race, or other health related factors prior to enacting the
regulations is unnecessary and disproportionate.146 As the CAS panel
pointed out, athletes, through no fault of their own, may not be able to
maintain the necessary testosterone level when undergoing
treatment.147 In other words, the treatment might not achieve the DSD
Regulations’ intended goal, and can put the athletes and their doctors
142. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 9–15 (2019) (summarizing the treatment Semenya underwent to
suppress her testosterone and explaining the mental strain it caused).
143. See id. at 116 (“[T]he athlete must bear the costs of her personal physician(s)
and of any treatment required to satisfy the Eligibility Conditions.”); see also
Karkazis & Carpenter, supra note 74, at 581–85 (distinguishing the impact on those
who undergo treatment from those who do not); Jordan-Young, supra at 76, at 2–3
(suggesting the treatment subjects intersex athletes to additional and unnecessary
costs that can end up being borne throughout an athlete’s lifetime).
144. But see Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v.
IAAF, CAS 2018/0/5798, 128 (2019) (explaining the long-term effects of the various
IAAF suggested treatments to lower testosterone).
145. See id. at 143–44 (holding that the regulations discriminate against a group
based on an immutable characteristic).
146. See Infra Part III(B)(iv) (explaining that the limited data from inaccurate
testing is unethical in violation of the Code); see also Jordan-Young, supra at 76, at
2–3 (suggesting that management of side effects only adds to the cost for athletes).
But see Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS
2018/0/5798, 159 (2019) (ignoring the side effects each athlete suffers from the
hormonal treatment).
147. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 156–57 (2019) (referring to Semenya’s testosterone level
fluctuations).
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in an uncomfortable predicament.148 The athlete may then be
prohibited from competing for yet another circumstance that is out of
their control, or the athlete’s physician may be required to double or
triple their dosage further threatening the athlete’s health.149
Consequently, World Athletics is impermissibly subjecting athletes
and their doctors to the DSD Regulations without fully analyzing and
contemplating the harmful and possibly unforeseen side effects.
iv. Athlete’s Health: Disproportionate Focus on Testosterone
Furthermore, World Athletics is sidestepping the underlying issue
of the binary framework by unnecessarily and disproportionately
focusing on testosterone.150 World Athletics enacted the DSD
Regulations under the false assumption that testosterone is the sole
variable giving athletes an unfair advantage by producing leaner body
mass.151 World Athletics fails to consider how other biological factors
(e.g. height, leg length, etc.) and outside factors (e.g. diet, training
resources, etc.), can impact an athlete’s performance and give an
athlete an advantage over competitors.152 Instead, World Athletics
relies on the historical assumption that classifications within sports
148. See WMA Response Letter, supra note 101 (discouraging doctors from
crossing an unethical line in prescribing the treatment without a pathological
reason).
149. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 156–57 (2019) (pointing out inconsistencies in the IAAF’s
approach to enforcing the DSD regulations).
150. See Peterson, supra note 48, at 329 (arguing that “fair play,” the principle
upon which the DSD Regulations were implemented, is a static concept that changes
“from time to time, from society to society”). But see Semenya v. IAAF, CAS
2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 146–47 (2019)
(agreeing with the IAAF in deciding that testosterone is the determinative factor in
how an athlete performs).
151. Contra Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v.
IAAF, CAS 2018/0/5798, 17–18 (2019) (pointing out Semenya’s time was faster
when her testosterone was suppressed); Semenya v. IAAF, CAS 2018/0/5794 &
Athletics South Africa v. IAAF, CAS 2018/0/5798, 9–53 (2019) (presenting
testimonies by physicians, doctors, and trainers that argued testosterone was not the
determinative factor in Semenya’s ability).
152. See Nguyen, supra note 48, at 63, 73 (arguing how focusing on testosterone
levels has facilitated sex verification testing even after the nude parades were put to
a stop); see also CAS Executive Summary, supra note 5, at 2–3 (noting that Semenya
provided multiple medical experts with knowledge of diagnosis, effects, and
treatment of DSD).
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should match the binary divide.153
By disproportionately focusing on testosterone, World Athletics’
pursuit to create fair competition is severely undermined by the binary
framework.154 Requiring athletes to compete against other athletes
with approximately the same level of testosterone would seem to level
the playing field if it is assumed testosterone is the determinative
factor in an athlete’s performance.155 In this sense, the DSD
Regulations are arguably on track to establishing fair competition;
however, the DSD Regulations are prevented from actually achieving
a level playing field because of the male/female binary divide.156 In
other words, World Athletics is trying to maintain the male/female
division when there is no obvious divide when it comes to
testosterone.157 Although the DSD Regulations are intended to create
fair competition, World Athletics will continue to be unsuccessful so
long as they continue to operate within the binary framework.158 Thus,
World Athletics is imposing an unnecessary and disproportionate
health risk on certain female athletes in violation of the Code.

153. E.g., Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 72 (2019) (explaining IAAF’s view that the only way to enable
an equal opportunity for female athletes to excel is by having separate categories for
males and females).
154. See CAS Executive Summary, supra note 5, at 2–3 (stating the panel’s
decision in Semenya’s case was limited to the binary framework since neither party
addressed nor challenged the binary framework of the male and female
classifications); see generally Eligibility Regulations for the Female Classification,
supra note 2 (stating a goal of fair competition).
155. See IAAF Letter to WMA, supra note 99 (focusing on an athlete’s
testosterone levels to determine which events she will be restricted from competing
in); CAS Executive Summary, supra note 5, at 4–6 (implying that testosterone must
be the determinative factor of an athlete’s performance when operating under the
binary framework).
156. See CAS Executive Summary, supra note 5, at 3 (suggesting CAS may have
decided the case in another way had the panel not been limited to assumption of the
binary framework).
157. See Krech, supra note 46, at 264, 269 (asserting that the binary framework
“can be regulated in a manner that, paradoxically, undermines [its] very aim”); see
also NAT’L GEOGRAPHIC, supra note 47 (reiterating testosterone levels range on a
spectrum when comparing multiple individuals).
158. E.g., Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 120 (2019) (“[N]ot all individuals’ bodies fit neatly into a single
binary male/female classification.”).
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B. DSD REGULATIONS VIOLATE THE SPIRIT OF SPORT
Sports remains a world-wide tradition because athletes continue to
achieve extraordinary success by their own natural ability, drive, and
determination.159 The international community champions athletes
who break records and truly win on their own accord as evidenced by
the Code’s inclusion of the spirit of sport.160 Requiring an athlete to
artificially limit their natural ability undermines the purpose of
safeguarding health, ethics, and fair play within international athletic
competitions.161 Thus, World Athletics’ new DSD Regulations violate
the Code’s “spirit of sport” element in three ways: (1) by unfairly
singling out a select group of athletes wanting to compete in certain
events, (2) by allowing those with artificial assistance and voluntary
biological changes to participate in the name of fair competition and
inclusion, and (3) by failing to completely test how testosterone affects
an athlete’s ability prior to enacting the regulations at the expense of
the athlete’s health and fundamental human rights.162
i. Singling Out a Select Group of Athletes
Ethics and fair play are of intrinsic value both under the Code and
in sports generally.163 As CAS admits, World Athletics’ regulations
are discriminatory in disproportionately targeting a select group of
female athletes based on an immutable characteristic.164 Thus, unfair
159. See World Anti-Doping Code, supra note 9, at 14 (explaining that the “spirit
of sport” has always encompassed the celebration of an athlete’s natural ability).
160. See About World Athletics, supra note 1 (noting that the IAAF was originally
created to produce and maintain a list of world records in track and field events); see
also World Anti-Doping Code, supra note 9, at 14 (stating that the “spirit of sport”
is the essence of Olympism).
161. See World Anti-Doping Code, supra note 9, at 14 (clarifying that “doping is
fundamentally contrary to the spirit of sport”).
162. See generally id. (explaining the Code’s rationale).
163. See id. at 14 (including ten other characteristics under the Code’s rationale
of the spirit of sport); see also Peterson, supra note 48, at 329, 332 (relying on the
ethic of fair play to argue against sex verification testing). Compare World AntiDoping Code, supra note 9, at 14 (relying on the goal of fair play), with Eligibility
Regulations for the Female Classification, supra note 2, at 1.1(a) (relying on the
goal of fair competition, which is the functional equivalent of the Code’s fair play).
164. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 142–44 (2019) (shifting the burden of proof from Semenya to the
IAAF to illustrate that the regulations were necessary and proportional); see also
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discrimination against intersex athletes only competing in the
restricted events is contrary to fair play in four ways.165
a. Discrimination: Natural Born Characteristics
First, the regulations unfairly discriminate against intersex athletes
based on a condition with which they were born.166 Intersex female
athletes are forced to consume oral contraceptives while non-intersex
female athletes are not.167 Intersex athletes are then subjected to an
additional time-consuming treatment, negative side effects, and
unnecessary stress that non-intersex athletes are not subjected to.168
Intersex athletes are also obligated to take on an unnecessary financial
burden that non-intersex athletes will never have to contemplate.169 In
comparison to non-intersex athletes, intersex athletes are unreasonably
forced to undergo treatment simply because the intersex athletes were
born with a slightly different genetic make-up.170
World Anti-Doping Code, supra note 9, at 14.
165. But see Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v.
IAAF, CAS 2018/0/5798, 144–60 (2019) (deciding the IAAF presented enough
evidence to overcome its burden of proving the discriminatory regulations were
necessary and proportional).
166. See Eligibility Regulations for the Female Classification, supra note 2, at
2.2(a) (stating the relevant athlete is one that has a condition that causes a higher
level of testosterone); see also CAS Executive Summary, supra note 5, at 6
(clarifying that CAS’s decision is not about wrong doing because Semenya was born
with the intersex condition and did not partake in doping).
167. Eligibility Regulations for the Female Classification, supra note 2, at 2.3
(requiring only female athletes who meet the standard of “relevant athlete” to
undergo testosterone-suppressing treatment). But see IAAF Letter to WMA, supra
note 99 (claiming athletes are free to participate in unrestricted events and any male
or intersex classified events).
168. Compare Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v.
IAAF, CAS 2018/0/5798, 12-14 (2019) (describing how Semenya’s diminished
health from the testosterone-suppressing treatment negatively impacted her mental
health and especially her mental focus during training), with IAAF Letter to WMA,
supra note 99 (claiming any burden, including a financial burden, is necessary and
proportional to the goal of fair competition), and Semenya v. IAAF, CAS
2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 71-108 (2019)
(reiterating IAAF’s argument that the DSD Regulations are the only way to ensure
a level playing field).
169. Supra Part III(A); see also Semenya v. IAAF, CAS 2018/0/5794 & Athletics
South Africa v. IAAF, CAS 2018/0/5798, 116 (2019) (quoting the IAAF’s refusal to
pay for treatment).
170. See generally IAAF Athletics, supra note 2 (defining relevant athlete for
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b. Discrimination: Restricted vs. Unrestricted Events
Second, the regulations unfairly discriminate against athletes
competing in the restricted events without a comparable regulation on
intersex athletes competing in the unrestricted events.171 Intersex
athletes, who choose not to take oral contraceptives, are allowed to
compete in a female classification event so long as the event’s distance
is not within 400m to one mile, or in any male classification event.172
Although World Athletics suggests that intersex athletes are not
discriminated against simply because they can still compete in other
events, World Athletics is ignoring the fact that the regulations are
preventing a select group of athletes from competing in whichever
event they choose based on an immutable characteristic.173 Intersex
athletes in Dutee Chand’s position, who can continue to train and
compete in the same events they have been competing in, have an
unfair advantage over intersex athletes in Semenya’s position, who
would have to change events after tirelessly training for and competing
in the restricted events.174 Thus, intersex athletes are limited in the
events in which they can compete without undergoing treatment, and
DSD Regulations).
171. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 10-12 (2019) (outlining Semenya’s argument that the restricted
events were arbitrarily selected since three out of top five largest correlated events
in IAAF’s study were not included under the regulations).
172. See IAAF Letter to WMA, supra note 99 (claiming that the IAAF regulations
“are not based on a single study, but on many scientific publications and
observations from the field during the past 15 years”). But see Semenya v. IAAF,
CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 10-14, 156
(2019) (noting that “the Panel has concerns about the adequacy of the evidentiary
basis for including the 1500m and one mile events within the list of Restricted
Events”), and Dutee Chand v. AFI & IAAF, CAS 2014/A/3759, 71 (2015) (noting
contention amongst expert’s regarding the influence of testosterone in Chand’s
athletics ability).
173. See Jordan-Young, supra note 76 (indicating that, if an athlete wants to
compete in any event she chooses, she is faced with the tough choice of submitting
to the regulations); see also Karkazis & Carpenter, supra note 74 (arguing the
regulations force athletes into an impossible choice).
174. Compare Chand v. AFI & IAAF, CAS 2014/A/3759 (2015) (allowing Chand
to continue competing in the 100m and 200m events without treatment), with
Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS
2018/0/5798 (2019) (requiring Semenya to undergo treatment to continue competing
in the 800m event).
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intersex athletes competing in the restricted events are unnecessarily
disadvantaged only because their bodies naturally produce a higher
level of testosterone.
c. Discrimination: Males vs. Females
Third, World Athletics has not implemented a comparable
regulation for male athletes.175 Under the binary framework, male
athletes are not limited in the amount of testosterone their bodies can
produce.176 Male athletes can naturally produce as little or as much
testosterone possible without being subjected to an unnecessary
medical treatment.177 By operating under the binary framework, World
Athletics is artificially placing a limit on female athletes’ testosterone
production but not on those of males.178 Moreover, no comparable
level-the-playing-field regulation exists for male athletes who produce
below the male-average level of testosterone.179 In other words,
restricting intersex female athletes’ testosterone would be the
equivalent of permitting male athletes with lower testosterone to
medically increase their testosterone to the average male range,
essentially authorizing steroid usage.180 Permitting such a regulation
would, however, contradict and violate the intrinsic value of ethics and
fair play in international sports, which the Code tries to prevent.181
World Athletics is, therefore, violating the spirit of sport by operating
175. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 142-44 (2019) (explaining the regulations are discriminatory
because there is not a comparable regulation for the male classification); see also
Peterson, supra note 48, at 332–33 (implying the binary divide is to blame for the
discriminatory regulations).
176. See Prohibited List, supra note 10 (prohibiting artificial testosterone).
177. See World Anti-Doping Code, supra note 9, at 14 (explaining why artificial
testosterone violates the spirit of sport); Eligibility Regulations for the Female
Classification, supra note 2.
178. See generally Peterson, supra note 48 (indicating that the binary framework
is an outdated framework to be operating within).
179. See generally Eligibility Regulations for the Female Classification, supra
note 2 (analogizing the lack of regulations for male athletes as an authorization of
steroid usage).
180. See generally id. (discussing the potential unintended consequences of
restricting intersex female athletes’ testosterone levels).
181. See World Anti–Doping Code, supra note 9, art. 4.3 (implying that allowing
males with lower testosterone to take testosterone enhancers would violate the
Code’s criteria of a prohibited substance).

564

AM. U. INT’L L. REV.

[35:3

within the restrictive binary framework.
d. Discrimination: Violating World Athletics’ Constitution
Even if the DSD Regulations are found not to violate the spirit of
sport through the three previous discrimination points, World
Athletics is undermining the spirit of sport by permitting the
discriminatory impact of the DSD Regulations in violation of its own
Constitution.182 World Athletics has voluntarily committed itself to
preserving every athlete’s right to compete without “unlawful
discrimination of any kind.”183 In other words, World Athletics has
committed itself to a higher standard.184
Subjecting a select group of female athletes to unnecessary medical
treatment without comparable regulations on other female and male
athletes is unlawfully discriminatory.185 Even though World Athletics
enacted a constitution that prohibits unlawful discrimination of “any
kind,” World Athletics claims this right is not absolute.186 To an extent,
regulations will impact one athlete differently than another.187
However, the differential impact cannot exceed an unnecessary or
disproportionate amount.188 Requiring athletes to hinder their natural
ability, only because of an immutable characteristic over which they
182. See IAAF Constitution, supra note 39, at 1, 48 (pledging that athletes
competing in IAAF sponsored events will be protected under the provisions of its
own constitution).
183. Id. (detailing the higher standard set forth by World Athletics).
184. See id. (noting that the IAAF created its own Constitution to “protect the
integrity of Athletics”).
185. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798 (2019) (holding regulations as discriminatory). But see IAAF
Letter to WMA, supra note 99 (claiming the regulations are necessarily
discriminatory and therefore lawful).
186. See IAAF Letter to WMA, supra note 99 (responding to criticisms of the
regulations and asserting the need to create fair competition); see also Semenya v.
IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 71101 (2019) (presenting expert witnesses who assisted in the testing to show how the
regulations are necessary).
187. See IAAF Letter to WMA, supra note 99 (noting the individualized nature
of addressing DSD); see also supra Part III(A).
188. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 144 (2019) (specifying the standard of proof is that differential
treatment must use necessary, reasonable, and proportionate means to a legitimate
objective to remain lawful).
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have no control, is the definition of impermissible disparate impact.189
Affected athletes are obligated to undergo health-altering treatment
that no other athlete even has to contemplate.190 World Athletics is
unethically violating its own constitution and, in turn, undermining the
spirit of sport.
ii. Artificial Assistance and Voluntary Biological Changes
Since fair play is of fundamental value to the spirit of sport, athletes
should be free to perform at their peak abilities.191 Therefore, fair
competition is impossible if athletes cannot compete within their own
natural abilities while those with artificial assistance and voluntary
biological changes can continue to compete.
a. Fair Competition Contradicted: Oscar Pistorius
In the case of Oscar Pistorius, preventing an amputee from
competing with artificial legs violated the spirit of sport and
undermined World Athletics’ goal of ensuring the maximum number
of people can compete and participate in track and field.192 Fair
competition for an amputee was created when CAS overturned World
Athletics’ prohibitive regulations finding that the artificial legs did not
give Pistorius total advantage over the able-bodied athletes.193 If the
spirit of sport was violated in prohibiting an amputee from competing,
preventing an athlete from competing at their natural level must also
189. See id. at 142-44. But see id. at 142–43 (summarizing IAAF’s argument that
competitions would be “arbitrary and irrational” if legal sex and gender identity were
to determine an athlete’s classification).
190. See supra Part III(A); see also WMA Initial Letter to IAAF, supra note 96
(discussing the inequitable treatment of athletes who undergo health-altering
treatment).
191. See World Anti-Doping Code, supra note 9, at 14 (implying fair play is
fundamental to the spirit of sport by including it in the Code).
192. See Pistorius v/ IAAF, CAS 2008/A/1480, 1 (Court of Arbitration for Sport,
May 16, 2008), https://jurisprudence.tas-cas.org/Shared%20Documents/1480.pdf
(deciding it was fair for Pistorius to compete with artificial legs).
193. Compare id. at 10–11 (stating the standard of proof was that Pistorius’s use
of artificial legs was an advantage over able-bodied athletes), with Semenya v. IAAF,
CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 142 (2019)
(explaining the standard of proof for the IAAF was to establish a degree of
competitive advantage that justifies subjecting female athletes to testosteronesuppressing treatment).
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violate the spirit of sport.194 In such a situation, the notion of fair play
becomes moot and ineffective.
b. Fair Competition Contradicted: Transgender Policy
Likewise, the trend of adapting anti-doping regulations to permit
transgender athletes to compete in competitions, while at the same
time limiting athletes’ natural ability based on testosterone level, is
contradictory.195 Both international and national sports organizations’
inclusion of transgender athletes, although commendable, are relying
on the false assumption that testosterone alone is the determinative
factor in an athlete’s level of performance.196 However, taking the
assumption that testosterone is the determinative factor as true,
including transgender athletes is creating an artificial divide between
males and females by permitting individuals to choose their
classification.197 Although discussion of transgender athletes in
international competitions is beyond the scope of this Comment,
permitting people to voluntarily change their classification while
simultaneously restricting intersex athletes from competing within
their natural abilities makes fair play seem only theoretical. Therefore,
the DSD Regulations violate the spirit of sport by contradicting the
notion of fair play.
iii. Failure to Test the Testosterone Impact
Subjecting athletes to a treatment with unnecessary side effects that
have not been fully tested goes against ethics and health under the
194. Compare Pistorius v/ IAAF, CAS 2008/A/1480, (2008), with Semenya v.
IAAF, CAS 2018/0/5794 &
Athletics South Africa v. IAAF, CAS 2018/0/5798 (2019).
195. Compare Sex Reassignment Regulations, supra note 108 (clarifying that the
Regulations do not apply to instances of female to male sex reassignment), with
Eligibility Regulations for the Female Classification, supra note 2 (focusing on
testosterone as the key factor is separating male and female competitors).
196. See supra Part III(A) (arguing the IAAF is relying on the false assumption
that testosterone is the determinative factor of an athlete’s performance); see also
Canadian Centre for Ethics, supra note 106, at 5-21 (addressing the intersection of
trans inclusion and testosterone levels in sports).
197. See supra Part III(A); see also Sex Reassignment Regulations, supra note
108 (allowing transgender athletes to compete in the female classification if their
testosterone meets a certain threshold by artificial means).
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spirit of sport.198 World Athletics’ claim that intersex athletes have an
unfair advantage over non-intersex athletes is based on incomplete and
inadequate testing.199
a. Inadequate Testing: All Athletes
First, by relying on limited data, World Athletics has failed to
reliably connect higher testosterone with an unfair advantage.200 As the
ASA stated, results from blood samples taken from athletes during
doping control tests without standardization in collection and testing
are inaccurate and unrepresentative of how testosterone actually
impacts an athlete’s ability.201 World Athletics submits that their
sampling pool was small, suggesting that the results of World
Athletics’ testing does not encompass sufficient information to
reliably determine whether intersex athletes have an unfair
advantage.202
b. Inadequate Testing: Only Intersex Female Athletes
World Athletics’ testing on athletes with suppressed testosterone
was likewise incomplete and inadequate.203 The World Athletics only
198. See World Anti-Doping Code, supra note 9, at 14; see, e.g., Semenya v.
IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 118
(2019) (“The IAAF is entrusted with enacting regulations to facilitate and ensure the
fair and principled administration of the sport of track and field for the benefit of all
athletes.”).
199. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 9-72 (2019) (criticizing the sample used for testing by first using
urine and blood samples originally taken for doping test and then only testing three
athletes with suppressed testosterone at random times).
200. See id. at 53-56 (challenging the methodology behind IAAF’s testing).
201. See id. at 144 (arguing the small sample size used by the IAAF and the lack
of standardization in testing deems the data unreliable and that IAAF’s criteria for
implementing regulations must be based on scientific judgements and not policy that
are free of conflicts of interest and studies that are transparent).
202. See Jordan-Young, supra at 76, at 2–3, (explaining the potential severity of
the side effects, an area largely left to uncertainty); see also Semenya v. IAAF, CAS
2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 53–56 (2019)
(requesting the regulations be suspended based on the breadth of data missing from
testing).
203. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 9-71 (2019) (summarizing Semenya’s and the ASA’s
overlapping arguments challenging IAAF’s testing methodology).
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relied on three samples of athletes, including Semenya, who
underwent the testosterone suppressing treatment.204 Blood samples
were taken from the athletes at random without standardization of
timing, whether the athlete was in the midst of rigorous training, or
were resting to prepare for an upcoming competition.205 As Semenya
stated, her testosterone levels were higher when she was resting or
doing light training, so when they tested her prior to a competition her
testosterone was naturally elevated and not an accurate indicator of
having an unfair advantage during the competition.206 Semenya also
ran one of her fastest times while undergoing treatment calling into
question the assumption that higher testosterone is directly correlated
to an unfair advantage.207 Thus, World Athletics’ reliance on random,
unstandardized data demonstrates an unethical use of science to
implement the DSD Regulations in violation of the Code.208
c. Inadequate Testing: Restricted vs. Unrestricted Events
Similarly, World Athletics acted unethically by arbitrarily applying
the regulations to restricted events without including other events with
a similar or greater correlation between athletic performance and
testosterone.209 Out of the twenty-one events considered, the DSD
Regulations only apply to the events that ranked second, fifth, sixth,
and tenth in strongest correlation.210 World Athletics excluded,
204. See id. at 53–56 (condemning IAAF’s testing pool); see also Nguyen, supra
note 48, at 66–72 (warning that testosterone testing will continue to subject female
athletes to gender verification testing and public humiliation).
205. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 53-56 (2019) (arguing the IAAF’s method was not transparent);
see also Jordan-Young, supra at 76, at 2-3 (criticizing IAAF’s failure to include
factors such as race and ethnicity that may have impacted the data).
206. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 53-56 (2019) (addressing the details of Semenya’s testimony).
207. See id. at 17–19 (noting that although Semenya won the Olympic gold medal
in 2016 after she stopped the testosterone-suppressing treatment, her time was still
slower than it was when she was undergoing the treatment in 2011).
208. See id. at 9-71 (arguing Semenya’s alleged 1-2% advantage over nonintersex athletes does not justify subjecting her to a health-altering treatment).
209. See id. at 156 (hinting to the IAAF that the inclusion of the 1500m and onemile events seem arbitrary and that it might be in the IAAF’s best interest to remove
those from the restricted events).
210. See id. at 11–12 (highlighting only four out of the twenty-one events are
restricted and three of which were not ranked within the top four largest
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without a valid reason, at least six events that resulted in a similar or
greater correlation between athletic performance and testosterone.211
Therefore, World Athletics unethically enacted the regulations by
arbitrarily imposing the regulations on the restricted events and not
similarly situated events.212
d. Inadequate Testing: Application
Furthermore, at the expense of the athletes’ health and well-being,
World Athletics is unreasonably imposing the oral contraceptive
treatment on athletes on the basis of inaccurate and incomplete
testing.213 Compelling female athletes to consume a substance they
would not otherwise consume infringes upon the athletes’
fundamental human rights and their abilities to control their bodies.214
Although World Athletics claims to provide athletes with an
opportunity to make a completely voluntary choice, the athletes, as
Human Rights Watch argues, cannot give informed and voluntary
consent so long as eligibility to compete remains dependent upon
abiding by the regulations.215 Athletes, like Semenya, are deprived of
correlations).
211. See id. at 156 (explaining that “the Panel has concerns about the adequacy
of the evidentiary basis for including the 1500m and one-mile events within the list
of Restricted Events.”).
212. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 11–13 (2019) (arguing that “athletic performance does not
correlate with significantly higher endogenous testosterone”); see generally World
Anti-Doping Code, supra note 9 (supporting fair play in international competitions).
213. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 45–47 (2019) (summarizing how a Human Rights Watch
researcher argued that the regulations violate athletes’ fundamental rights to privacy,
to health, and to control what goes in their bodies); see also supra Part III(A)
(explaining how the side effects of the oral contraceptive treatment harms the
athletes’ physical health undermining the goal of fair competition). But see Semenya
v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, CAS 2018/0/5798, 15
(2019) (rejecting the arguments made by the Human Rights Watch as not
“particularly useful”); see generally United Nations, supra note 82 (resolution to
condemn IAAF’s DSD Regulations).
214. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 45-47 (explaining that the Human Rights Watch is against the
DSD Regulations).
215. See supra Part III(A) (arguing the regulations remove the athlete’s
independent choice to undergo a health-altering treatment); see also Karkazis &
Carpenter, supra note 74, at 581–85 (suggesting affected athletes do not have a real

570

AM. U. INT’L L. REV.

[35:3

their abilities to make decisions about their bodies without outside
pressure.216 The regulations also infringe on an athlete’s right to
privacy if they choose to not undergo treatment and suddenly stop
competing in restricted events.217 For instance, a female athlete who
starts competing within the male classification will essentially make it
publicly known that she is an intersex athlete subjected to the
regulations.218 In other words, the female athlete will lose her right to
confidentiality under the DSD Regulations.219 Thus, the DSD
Regulations unnecessarily and disproportionately violate athletes’
fundamental human rights by putting them in an unethical
predicament where they are unable to control what goes in their body
and, in some cases, lose their right to privacy.220
Along those lines, the treatment also subjects athletes to
unnecessary emotional distress from the constant evaluation of
whether athletes, like Semenya and Chand, are female enough.221 The
ASA states that because there is no means of testing an athlete’s
androgen receptor sensitivity, which is responsible for the production
of higher testosterone, athletes will be subjected to visual inspection
choice); cf. Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 45-47 (outlining Human Rights Watch’s testimony); see also
WMA Initial Letter to IAAF, supra note 96 (urging that the DSD regulations require
athletes to take oral contraceptives “not based on medical need”).
216. See Karkazis & Carpenter, supra note 74, at 581–85; see also WMA Initial
Letter to IAAF, supra note 96; Semenya v. IAAF, CAS 2018/0/5794 & Athletics
South Africa v. IAAF, CAS 2018/0/5798, 45–47 (2019).
217. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 45–47 (2019) (stating that the DSD Regulations will have the
effect of “coercing” some women to undergo unnecessary medical procedures).
218. See id. at 45–47 (arguing the confidentiality provision of the regulations
cannot be upheld putting another outside pressure on athletes to undergo treatment).
But see id. at 155 (addressing the confidentiality concerns as an “inevitable
detrimental effect” that is not worthy of rendering the regulations disproportionate).
219. See id. at 45-47 (outlining Human Rights Watch’s testimony).
220. See id.; see also supra Part III(A).
221. See Nguyen, supra note 48, at 63, 73–74 (contending that testosterone testing
is subjecting athletes to negative psychological effects caused by social scrutiny of
their bodies); see also Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa
v. IAAF, CAS 2018/0/5798, 19-20 (2019) (quoting Chand who stated she no longer
participates in national team training camps because of the constant public
speculation of her body and the bullying and hostility she faced from other
competitors).
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of their bodies.222 As the Human Rights Watch points out, the DSD
Regulations are open to abuse in providing sole authority to World
Athletics officials to investigate any athlete they believe to have higher
levels of testosterone.223 Female athletes will have to endure scrutiny
of their bodies through “subjective and discriminatory frameworks
and stereotypical understandings.”224 The DSD Regulations are
repeating history by subjecting athletes to a version of the nude
parades that previous athletes vigorously protested and temporarily
ended.225 World Athletics is therefore imposing an unnecessary
emotional burden on athletes without substantial testing and
understanding of how intersex athletes’ higher testosterone levels truly
impact their abilities.226 Thus, the DSD Regulations are violating the
spirit of sport by relying on unethical testing to subject athletes to
unnecessary health risks in the name of fair competition.227

IV. RECOMMENDATIONS
Fair competition and a level playing field are the foundation of
international sports.228 As the international governing body of track
222. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
CAS 2018/0/5798, 53–56 (2019) (summarizing ASA’s arguments); see also Adair,
supra note 51, at 132–37 (illustrating the history of sex verification and why athletes
have historically challenged each version of the test).
223. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
45–46 (2019); Adair, supra note 51, at 132–37 (arguing that IAAF has failed to
refrain from discrimination, “[i]nstead, it has actively engaged in it”).
224. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
45–46 (2019); See Krech, supra note 74, at 269–71 (illuminating how the binary
framework harms intersex athletes); see also Peterson, supra note 48, at 332–33
(arguing the sex-verification process discriminates against intersex athletes because
the process operates under the assumption that sex is binary).
225. See Nguyen, supra note 48, at 66-75 (criticizing sex verification testing); see
also supra Part II(B)(i) (providing history of the nude parades).
226. See generally Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa
v. IAAF, 9–71 (2019) (outlining arguments presented by Semenya and ASA).
227. See generally World Anti-Doping Code, supra note 9; Semenya v. IAAF,
CAS 2018/0/5794 & Athletics South Africa v. IAAF, 5–199 (2019) (listings specific
adverse health risks by undergoing medical treatments); Eligibility Regulations for
the Female Classification, supra note 2.
228. See World Anti-Doping Code, supra note 9, at 14 (explaining the purpose of
the Code is to maintain fair competition by awarding the natural abilities of the
athletes); see also Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v.
IAAF, 145 (2019) (holding fair competition is a legitimate goal).
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and field, World Athletics is tasked with safeguarding fair play in track
and field events.229 World Athletics has failed to live up to the task in
implementing the DSD Regulations and violating the Code.230
However, three recommendations can be made to bring World
Athletics back into greater compliance with the Code and
simultaneously maintain fair competition. World Athletics can (1)
eliminate the binary classification and implement testosterone-based
classifications or (2) maintain the binary classification but implement
testosterone-based subclassifications within the male and female
classifications. WADA should also implement stronger safeguards in
the Code to prevent comparable regulations from being enacted and to
pressure sports organizations to safeguard the health of athletes and to
uphold the spirit of sport. Therefore, the implementation of these
recommendations will eliminate the need for forced oral
contraceptives and bring World Athletics back into compliance with
the Code.

A. ELIMINATING THE BINARY DISTINCTION
As long as World Athletics operates under the assumption that
testosterone is the determinative factor of an athlete’s performance,
World Athletics should eliminate the binary classification distinction
between males and females.231 By removing this sharp distinction,
classifications of international competitions will be forced to align
with the true nature of sex as defined on a spectrum.232 Classifications
or divisions would instead be grouped based on testosterone levels. If
testosterone is truly the determinative factor, creating classifications
based on testosterone levels will create a more level playing field than
the male and female distinction.
229. See About the IAAF, supra note 1 (describing IAAF’s governing authority
within track and field); see also Code Signatories, supra note 7 (obligating the IAAF
to the Code).
230. See supra Part III (arguing the regulations pose a threat to athlete’s health
and compromise the spirit of sport).
231. See supra Part III (A), (B)(iii) (criticizing the IAAF’s assumption that
testosterone alone determines athletic performance).
232. See Krech, supra note 46, at 269–71 (arguing for more accountability among
organizations relying on the false assumption of the binary framework). But see
Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF, 71-108
(2019) (arguing for maintaining the binary classification).
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Under a testosterone-based system, athletes would compete against
competitors within the same bracket level of testosterone. As science
develops, the classification could become more defined. In other
words, World Athletics may want to start with only two categories,
above and below five (5) nmol/L, and then later break down the
categories into smaller increments of testosterone levels. The more
precise the categories, the more realistic fair competition will become.
Eliminating the binary divide and implementing testosterone-based
classifications will eradicate the issues of intersex female athletes
competing against non-intersex female athletes that drove World
Athletics to enact the DSD Regulations.233 Intersex female athletes
would then compete against other athletes with a similar level of
testosterone.234 All events would be open to them and they would no
longer need to undergo the oral contraceptive treatment, allowing
them to compete to their best ability.

B. CREATING TESTOSTERONE BASED SUBCLASSIFICATIONS
Realistically, the international sports world is not ready to eliminate
the binary classification, especially since many other elements factor
into an athlete’s performance.235 World Athletics should instead
implement subclassifications under the male and female
classifications. The subclassifications would replicate the weight class
categories used in wrestling matches but with testosterone levels.236 In
other words, under the female classification World Athletics would
separate events between a lower and a higher level of testosterone,
233. See supra Part II(B) (“Road to Enactment”).
234. But see Individuals with Intersex Conditions, AMERICAN PSYCHOLOGICAL
ASSOC. (2019) https://www.apa.org/topics/lgbt/intersex (stating that approximately
1 in every 1,500 babies is born intersex, which suggests limiting intersex athletes to
only competing against each other severely reduces the number of competitors and
removes intersex athletes from any real competition).
235. See CAS Executive Summary, supra note 5, at 3 (noting that neither
Semenya and ASA nor the IAAF challenged the binary classifications); see also
Adair, supra note 51, at 133–34 (suggesting that maintaining the binary
classification was the underlying purpose of the sex verification tests and nude
parades).
236. See Anna Boyd, Back to the Binary: How the Olympics Struggle with
Separation of Male and Female, 14 DEPAUL J. SPORTS L. 1, 29–31 (2018)
(proposing that the Olympics implement categories based on hormonal ranges
similar to wrestling’s weight classes).
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thus permitting female athletes to compete against other females
within the same testosterone class.237 World Athletics would need to
implement a similar division under the male classification to prevent
any unfair discrimination claims.238 Similar to the first
recommendation, World Athletics could initially make two
subdivisions of below and above five (5) nmol/L and then later divide
into smaller brackets of testosterone levels.
Likewise, implementing testosterone classes within the female
classification will eliminate the concerns of intersex female athletes
having an unfair advantage.239 Semenya and similarly situated athletes
would be able to compete in whichever event they choose without the
unnecessary physical, psychological, or financial burdens of the DSD
Regulations.240 World Athletics would no longer subject intersex
athletes to an unreasonable predicament and would no longer violate
the Code. Therefore, World Athletics should remove the DSD
Regulations and implement testosterone subclassifications within the
male and female categories.

C. IMPLEMENTING STRONGER SAFEGUARDS IN THE CODE
As sports organizations grapple with issues of fair play arising from
sex defined as a spectrum rather than a binary divide, WADA should
implement stronger safeguards to prevent another signatory from
mandating an unnecessary health-altering medical treatment.241
237. But see Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v.
IAAF, 155 (2019) (noting the issue of confidentiality may continue to be an
“inevitable detrimental effect”); Individuals with Intersex Conditions, supra note
234 (suggesting that since there is a small number of intersex athletes, dividing the
female classification would further remove intersex athletes from competitive
races).
238. See Semenya v. IAAF, CAS 2018/0/5794 & Athletics South Africa v. IAAF,
142–44 (2019) (holding the DSD Regulations as prima facie discriminatory because
there is not a comparable regulation applied to male athletes).
239. See Eligibility Regulations for the Female Classification, supra note 2
(implementing the oral contraceptive treatment under the assumption that intersex
female athletes have an unfair advantage).
240. See supra Part III(A),(B)(iii) (describing the negative side effects of
imposing the regulations).
241. See Who We Are, supra note 8 (stating WADA is responsible for enforcing
and updating the Code as needed); see also WADA Code Signatories, supra note 7
(obligating IAAF to any changes made to the Code by WADA).
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WADA can create stronger safeguards in two ways. First, WADA
should amend the prohibited list to include the oral contraceptives of
the DSD Regulations.242 By doing this, any organization that requires
athletes to undergo oral contraceptive treatment will directly violate
the Code. Athletes will also have a stronger basis and support for
challenging the regulation.243
Second, WADA should add an additional criterion that renders the
DSD Regulations and comparable regulations in violation of the
Code.244 In addition to the characteristics of creating an unfair
advantage, potentially harming an athlete’s health, and violating the
spirit of sport, WADA should include any regulation by a sports
organization that obligates a medical treatment to athletic eligibility.
Challengers would only need to demonstrate how a regulation meets
two of the characteristics, similar to how it is now.245 Adding the
additional criteria will give challengers a stronger foundation to argue
against the regulation as well as providing sports organizations with
ample notice that they will violate the Code if they enact similar
regulations. Therefore, WADA can support fair play by amending the
Code with stronger safeguards.

V. CONCLUSION
Analysis of World Athletics’ enacted DSD Regulations
demonstrates how subjecting athletes to unnecessary medical
treatment to maintain eligibility status is both violative of the Code
and fundamentally wrong. As sex has been defined as a spectrum
rather than a binary divide, sports organizations have questioned
where intersex athletes fit in. In operating under the binary framework,
intersex female athletes seem to have an unfair advantage over non242. See World Anti-Doping Code, supra note 9, at 4.3.1 (criteria for adopting a
substance or method to the prohibited list).
243. But see, e.g., Dutee Chand v. AFI & IAAF, supra note 62, at 142 (allowing
the IAAF to further study the issue and requiring Chand to respond to any new
information gathered by IAAF). See Semenya v. IAAF, CAS 2018/0/5794 &
Athletics South Africa v. IAAF, 142-60 (2019) (denying Semenya’s argument against
the oral contraceptive treatment).
244. See World Anti-Doping Code, supra note 9, at 14, 4.3.1 (defining the spirit
of sport and the criteria for meeting the level of a prohibited substance).
245. See id. at 30.
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intersex female athletes because their testosterone is at a higher level
allowing them to naturally produce leaner body mass. Thus, the World
Athletics was confined by the binary divide leading to the DSD
Regulations that unnecessarily impose oral contraceptives on intersex
female athletes.
However, World Athletics simultaneously violated the Code. A
signatory, such as the World Athletics, violates the Code by
implementing regulations that can potentially harm the health of
athletes and that undermines the spirit of sport. In deciding Semenya’s
case, CAS incorrectly excluded long-term side effects and the
financial burden that will most likely negatively impact the health of
Semenya and similarly situated athletes. The time differing, health
hindering, and financially detrimental treatment of the DSD
Regulations is both unnecessary and disproportionate to the goal of
fair competition.
Similarly, the DSD Regulations violate the spirit of sport by
unfairly discriminating against intersex female athletes without
comparable regulations for non-intersex female athletes, intersex
athletes competing in unrestricted events, and male athletes. Hindering
an intersex athlete’s natural ability while allowing amputees to
compete with artificial assistance and transgender athletes to compete
in the classification that matches their identity makes the notion of fair
play ineffective and only theoretical. Violating an athlete’s right to
control what goes in her body based on inadequate testing also
undermines ethics and fair play. Thus, the DSD Regulations violate
the Code by threatening athletes’ health and contradicting the spirit of
sport.
To again comply with the Code, World Athletics must remove the
DSD Regulations and reconsider how to create fair play in the sport of
track and field. World Athletics, WADA, CAS, and all other
international and national sports organizations must re-evaluate what
fair competition and the spirit of sport actually entail, so that no other
athlete is subjected to such an unnecessary and disproportionate
regulation.

